Status:
UNKNOWN
Neurostimulation Applied to Fibromyalgia
Lead Sponsor:
Federal University of Paraíba
Conditions:
Fibromyalgia
Eligibility:
FEMALE
25-60 years
Phase:
NA
Brief Summary
NeuroFibro is a double-blind, randomized, placebo-controlled clinical trial, using neurostimulation in women with fibromyalgia.
Eligibility Criteria
Inclusion
- (1) diagnosis of fibromyalgia, according to the American College of Rheumatology criteria;
- (2) been diagnosed for at least three months;
- (3) be female;
- (4) be in the age group between 25 and 60 years of age; and
- (5) sign the consent form.
Exclusion
- (1) cognitive deficit, evaluated through the Mini Mental State Examination (MMSE);
- (2) illiterate;
- (3) people with metallic implants located on the head, cochlear implants and cardiac pacemaker;
- (4) history of convulsion;
- (5) severe depression, measured by score greater than 36 on Beck Depression Inventory; and
- (6) be pregnant.
Key Trial Info
Start Date :
May 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT03384888
Start Date
May 15 2017
End Date
May 1 2020
Last Update
January 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Federal da Paraiba
João Pessoa, Paraíba, Brazil, 58.051-900